Roivant Sciences Ltd (ROIV)

New Form 8-K - Roivant Sciences Ltd. Filed: 2025-08-11 AccNo: 0001140361-25-029998 Size: 383 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Apogee Therapeutics Inc (APGE)

New Form 8-K - Apogee Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106228 Size: 518 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Immunovant Inc (IMVT)

New Form 8-K - Immunovant, Inc. Filed: 2025-08-11 AccNo: 0001764013-25-000128 Size: 247 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

BioCryst Pharmaceuticals Inc (BCRX)

New Form 8-K - BIOCRYST PHARMACEUTICALS INC Filed: 2025-08-11 AccNo: 0001171843-25-005265 Size: 187 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Kymera Therapeutics Inc (KYMR)

New Form 8-K - Kymera Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106227 Size: 451 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Humacyte Inc (HUMAW)

New Form 8-K - Humacyte, Inc. Filed: 2025-08-11 AccNo: 0001818382-25-000122 Size: 366 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits